Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- sangramento retal
- diarreia
- sangue nas fezes
Outros fatores diagnósticos
- dor abdominal
- artrite e espondilite
- desnutrição
- desconforto abdominal
- febre
- perda de peso
- constipação
- erupção cutânea
- uveíte e episclerite
- palidez
Fatores de risco
- história familiar de doença inflamatória intestinal
- antígeno leucocitário humano-B27
- infecção
- uso de anti-inflamatórios não esteroidais (AINEs)
- não fumante ou ex-fumante
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- estudos das fezes para patógenos infecciosos
- calprotectina fecal (CF)
- Hemograma completo
- perfil metabólico completo (incluindo testes da função hepática)
- velocidade de hemossedimentação (VHS)
- proteína C-reativa
- radiografia abdominal simples
- sigmoidoscopia flexível
- colonoscopia
- biópsias
Investigações a serem consideradas
- Tomografia computadorizada (TC)
- ultrassonografia intestinal
Algoritmo de tratamento
Colaboradores
Autores
Andrew Poullis, BSc, MBBS, MD, FRCP
Consultant Gastroenterologist
Department of Gastroenterology
St George’s Hospital
London
UK
Declarações
AP is an author of a reference cited in this topic.
Sailish Honap,
Consultant Gastroenterologist
Department of Gastroenterology
St George’s Hospital
London
UK
Declarações
SH has received honoraria from Pfizer (speaker, consultant, advisory board member, and received travel grants), Janssen (speaker fees, travel grants), AbbVie (speaker fees, consultant, travel grants), Takeda (speaker fees), Ferring (travel grants), Pharmacosmos (travel grants), Galapagos (travel grants).
Kamal Patel,
Declarações
all disclosures
Aaron Bhakta, BMedSci (Hons), BMBS, MSc, MRCP
Clinical Fellow in Gastroenterology
Department of Gastroenterology
St George’s Hospital
London
UK
Declarações
AB declares that he has no competing interests.
Agradecimentos
Dr Hesam A. Nooredinvand, and Dr Andrew Poullis would like to gratefully acknowledge Dr Ben Shandro, Dr Anet Soubieres, Dr Rhys Hewett, Dr Willem J.S. de Villiers, and Dr Houssam Mardini, previous contributors to this topic.
Declarações
BS, AS, RH, WJSD, and HM declare that they have no competing interests.
Revisores
Trevor Winter, MD, PhD
Associate Professor of Medicine
Division of Digestive Diseases and Nutrition
University of Kentucky
Lexington
KY
Declarações
TW declares that he has no competing interests.
Sharon Stein, MD
Assistant Professor of Surgery
Division of Colon and Rectal Surgery
University Hospital Case Medical Center
Cleveland
OH
Declarações
SS received a fee for educational courses on laparoscopic surgery, paid for in part by Covidien, Olympus, and Applied Medical.
Referências
Principais artigos
World Gastroenterology Organisation. Global guidelines: inflammatory bowel disease. Aug 2015 [internet publication].Texto completo
Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019 Mar;114(3):384-413. Resumo
Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020 Apr;158(5):1450-61.Texto completo Resumo
Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017 Jul 1;11(7):769-84.Texto completo Resumo
National Institute for Health and Care Excellence (UK). Ulcerative colitis: management. May 2019 [internet publication].Texto completo
National Institute for Health and Care Excellence. Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas. Sep 2022 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
O uso deste conteúdo está sujeito ao nosso aviso legal